Related Experiment Video
Updated: Jun 3, 2026
04:41
Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration
Published on: January 9, 2020
[An association study of COMT gene polymorphisms with schizophrenia]
Fan-zhi KONG1, Zhi-zhen PENG, Ting-yun JIANG
1Guangdong Academy of Medical Science, Guangdong Provincial People's Hospital, Guangdong Provincial Mental Health Institute, Guangzhou, Guangdong, 510120 P. R. China.
Summary
Investigating the catechol-O-methyl transferase (COMT) gene and schizophrenia in China revealed no significant association with individual single nucleotide polymorphisms (SNPs). However, specific COMT gene haplotypes may offer protection against schizophrenia.
Area of Science:
- Genetics
- Neuroscience
- Psychiatry
Context:
- Schizophrenia is a complex psychiatric disorder with a significant genetic component.
- The catechol-O-methyl transferase (COMT) gene plays a crucial role in dopamine metabolism, a neurotransmitter implicated in schizophrenia.
- Genetic variations in the COMT gene have been investigated for their association with schizophrenia risk.
Purpose:
- To examine the association between eight single nucleotide polymorphisms (SNPs) in the COMT gene and schizophrenia in the Yuedong-Chaoshan region of China.
Summary:
- Eight specific SNPs in the COMT gene were genotyped in 279 schizophrenia patients and 100 healthy controls.
- No significant association was found between individual SNPs and schizophrenia susceptibility.
- However, certain haplotypes, specifically (G)-G-A-A (rs4680-rs165599-rs2075507-rs6269) and A-A-C-(G) (rs2075507-rs6269-rs4633-rs6267), showed a potential association with schizophrenia.
Impact:
- The findings suggest that individual SNPs in the COMT gene are unlikely to be major risk factors for schizophrenia in this Chinese population.
- The study highlights the potential role of COMT gene haplotypes in conferring protection against schizophrenia.
- Further research into COMT haplotypes may provide insights into the genetic underpinnings of schizophrenia.
Related Concept Videos
01:29Biological Causes of Schizophrenia
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.
01:28Human Genetics
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
01:11Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
01:29Psychological and Sociocultural Causes of Schizophrenia
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:27Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...